Ikarian Capital, LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$235,000
-68.7%
410,189
-29.5%
0.04%
-56.6%
Q1 2022$751,000
+19.2%
582,137
+5.2%
0.10%
+5.3%
Q4 2021$630,000
-25.6%
553,2730.0%0.09%
+56.7%
Q3 2021$847,000
-68.7%
553,273
-59.5%
0.06%
-72.6%
Q2 2021$2,703,0001,365,0590.22%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 51,989$79,543,0000.24%
ASSET MANAGEMENT CORP /IL/ /ADV 133,500$204,0000.10%
Ikarian Capital, LLC 553,273$847,0000.06%
McAdam, LLC 55,978$86,0000.01%
JGP Wealth Management, LLC 15,000$23,0000.01%
Prospera Financial Services Inc 30,300$46,0000.00%
Fort Point Capital Partners LLC 10,000$15,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 55,599$85,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 6,501$10,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,800$76,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders